Nuclear Medicine: Page 93

Cardinal Health to sell China business

By AuntMinnie.com staff writers

Radiopharmaceutical supplier Cardinal Health has signed a definitive agreement to sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding for $1.2 billion.

November 14, 2017

FDG-PET/CT could improve treatment for NSCLC patients

By AuntMinnie.com staff writers

Using FDG-PET/CT, researchers in Italy have found a correlation between cell-free tumor DNA circulating in the bloodstream and the aggressiveness of tumors in patients with advanced non-small cell lung cancer (NSCLC), according to a study published in the November issue of the Journal of Nuclear Medicine.

November 8, 2017

CellSight creates partnership for PET tracer

By AuntMinnie.com staff writers

PET imaging firm CellSight Technologies is collaborating with Boehringer Ingelheim to evaluate its VisAcT PET imaging tracer for future use in the development and monitoring of immune-oncological therapies.

November 8, 2017

Sterigenics takes on new identity as Sotera

By AuntMinnie.com staff writers

Sterigenics International, the parent company of Canadian isotope firm Nordion and sterilization services vendor Sterigenics, has changed its name to Sotera Health.

November 7, 2017

Digirad revenues dip, net loss widens in Q3

By AuntMinnie.com staff writers

Slower than expected sales of capital equipment led to an 8% drop in revenue and a significantly higher net loss for nuclear medicine firm Digirad in its third quarter.

November 6, 2017

Cardinal Health names new CEO, posts lower profit in Q1

By AuntMinnie.com staff writers

Radiopharmaceutical supplier Cardinal Health has appointed chief financial officer Mike Kaufmann as its new CEO, effective January 1, 2018.

November 5, 2017

Deep learning can predict stenosis on fast SPECT-MPI

By Erik L. Ridley

Friday, December 1 | 11:00 a.m.-11:10 a.m. | SST02-04 | Room E450AResearchers have found that deep learning can improve the detection of potentially significant ischemic defects on raw, high-speed SPECT myocardial perfusion imaging (MPI) studies.

November 5, 2017

Cerveau's PET agent to be used in Alzheimer's trial

By AuntMinnie.com staff writers

Cerveau Technologies has announced a research collaboration involving the use of its investigational PET imaging agent (MK-6240) to study Alzheimer's disease.

October 29, 2017

Navidea signs Cerveau to PET agent deal

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has sublicensed its NAV4694 PET imaging agent to Cerveau Technologies.

October 29, 2017

Newfoundland to welcome 1st PET/CT scanner

By AuntMinnie.com staff writers

The Canadian province of Newfoundland and Labrador is getting its first PET/CT scanner.

October 25, 2017

SNMMI sets AUC guidelines for malignant disease

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG-PET/CT in restaging and treatment response for malignant disease.

October 24, 2017

How do seniors react to amyloid-PET results?

By Wayne Forrest

When told that PET scans have revealed elevated levels of beta-amyloid plaque in their brains, senior citizens feel frustrated and ask for more information about their chances of developing Alzheimer's disease, according to a study published online October 23 in JAMA Neurology.

October 24, 2017

Previous Page

Page 93 of 445

Next Page